Article Details
Retrieved on: 2023-10-12 14:40:39
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Research is underway to determine whether monoclonal antibodies targeting interleukin (IL)-4, IL-5, and IL-13 that disrupt Th2 cell–related pathways ...
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here